Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Biomerica Reports Fiscal 2021 Second Quarter Financial Results and Provides Business Update
Biomerica, Inc.January 15, 2021 GMT
Biomerica expects completion of enrollment of its Irritable Bowel Syndrome Diagnostic-Guided Therapy clinical trial by end of April, 2021
FDA actively reviewing Company’s EUA submission for its first of its kind “at-home” Blood Collection kit used with the Biomerica COVID-19 IgG ELISA Lab Test system
Simple to use 15-minute COVID-19 Antigen Rapid Test, which now has CE Mark, receives first large orders
IRVINE, Calif., Jan. 15, 2021 (GLOBE NEWSWIRE) Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, today announced financial results for its second quarter of fiscal year 2021, which ended November 30, 2020.